BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35634790)

  • 21. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Niu M; Combs SE; Linge A; Krause M; Baumann M; Lohaus F; Ebert N; Tinhofer I; Budach V; von der Grün J; Rödel F; Grosu AL; Multhoff G
    Radiat Oncol; 2021 Jul; 16(1):141. PubMed ID: 34332614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
    Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment prioritization and risk stratification of head and neck cancer during COVID-19 pandemic: A systematic review.
    Adham M; Anam K; Reksodiputro L
    Med J Malaysia; 2022 Jan; 77(1):53-59. PubMed ID: 35086995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of allied healthcare professionals in head and neck cancer surveillance: A systematic review.
    Rocke J; Mclaren O; Hardman J; Garas G; Smith ME; Ishii H; Constable J; Tikka T; Wie Liu Z; Williams R;
    Clin Otolaryngol; 2020 Jan; 45(1):83-98. PubMed ID: 31670912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing patients' fears of recurrence and fears of COVID-19 when considering their preference for review consultations.
    Dimelow J; Lowe D; Rogers SN
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4441-4448. PubMed ID: 33582851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restructuring emergency eye services during COVID-19 in a tertiary referral centre.
    Moussa G; Mushtaq F; Mandal P; Mathews N; Royal B; Manjunatha N; Lee R
    Br J Hosp Med (Lond); 2020 Dec; 81(12):1-8. PubMed ID: 33377847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of remote versus face-to-face ear, nose and throat outpatient consultation on patient pathways.
    Gupta T; Bhutta MF
    Ann R Coll Surg Engl; 2023 Jul; 105(6):561-567. PubMed ID: 36688846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delays in diagnosis, referral and management of head and neck cancer presenting at Kenyatta National Hospital, Nairobi.
    Onyango JF; Macharia IM
    East Afr Med J; 2006 Apr; 83(4):85-91. PubMed ID: 16863003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of coronavirus disease 2019 on suspected head and neck cancer two-week-wait referrals.
    Bhamra N; Gorman B; Arnold W; Rajah A; Jolly K; Nieto H; Fussey J; Liew L
    J Laryngol Otol; 2022 Mar; 136(3):248-251. PubMed ID: 34158135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the Head and Neck cancer-specific Patient Concerns Inventory (PCI-HN) in telephone consultations during the COVID-19 pandemic.
    Kanatas A; Rogers SN
    Br J Oral Maxillofac Surg; 2020 Jun; 58(5):497-499. PubMed ID: 32340765
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer.
    Agrawal A; deSilva BW; Buckley BM; Schuller DE
    Laryngoscope; 2004 Feb; 114(2):232-5. PubMed ID: 14755196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient Satisfaction With the Head and Neck Cancer Telephone Triage Service During the COVID-19 Pandemic.
    Zhu Y; Chen Z; Ding A; Walter H; Easto R; Wilde A
    Cureus; 2021 Sep; 13(9):e18375. PubMed ID: 34729263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of EASE: a psychosocial program to improve symptom management in head and neck cancer patients.
    Kilbourn KM; Anderson D; Costenaro A; Lusczakoski K; Borrayo E; Raben D
    Support Care Cancer; 2013 Jan; 21(1):191-200. PubMed ID: 22699303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
    Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
    Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals.
    Tikka T; Pracy P; Paleri V
    Clin Otolaryngol; 2016 Feb; 41(1):66-75. PubMed ID: 26611658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can head and neck cancer patients be discharged after three years?
    Kumar R; Putnam G; Dyson P; Robson AK
    J Laryngol Otol; 2013 Oct; 127(10):991-6. PubMed ID: 24107236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact and prevalence of SARS-CoV-2 in patients with head and neck cancer and acute upper airway infection in a tertiary otorhinolaryngology referral center in Denmark.
    Andersen PA; Rasmussen KMB; Channir HI; von Buchwald C; Cayé-Thomasen P; Klokker M; Knudsen JD; Kirkby NS; Aanaes K; Jensen RG
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3409-3415. PubMed ID: 33388982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of telephone consultations for head and neck cancer follow up: a patient satisfaction survey.
    Stewart R; Collins L; Kerr B; Gray G; Devlin B; Black M; Ullah R
    J Laryngol Otol; 2021 Sep; 135(9):815-819. PubMed ID: 34294168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 impact on the management of head and neck cancer: a French single-centre experience.
    Clementine M; Camille C; Swann A; Alavi Z; Remi M; Jean-Christophe L
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):873-882. PubMed ID: 37845381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.